Arkolith/Insider Trading/ENOB/Form 4

Sindlev Rene

Director, 10% OwnerEnochian Biosciences Inc (ENOB) · full profile →Form 4 · filed Mar 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2023Grant(A)877K$1.14$1.0M10.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2023Grant(A)439K—$0439K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-23-000444) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML